| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |